首页 > 市场调查报告书 > 製药

呼吸器

市场调查报告书

商品编码

1741288

胸膜疾病市场按疾病类型、诊断工具、治疗方法、最终用户和地区划分

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年胸膜疾病市场规模为 57.6 亿美元，到 2032 年将达到 93.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.2%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	57.6亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	7.20%	2032年价值预测	93.7亿美元

胸膜疾病涵盖多种影响胸膜（包裹肺部的薄膜）的疾病。这些疾病会对呼吸功能和整体健康产生重大影响。胸膜透过提供润滑并使呼吸顺畅，在维持肺部结构和功能完整性方面发挥着至关重要的作用。胸膜疾病的诱因多种多样，例如感染疾病、发炎、肿瘤以及接触有害物质。常见的胸膜疾病包括胸膜炎、胸腔积水、气胸和间皮瘤。识别症状、准确诊断并实施适当的治疗策略，对于管理和改善全球范围内受这些棘手胸膜疾病影响患者的预后至关重要。多年来，全球胸膜疾病市场一直稳定成长，这得益于吸烟、结核病和转移等相关风险因素的盛行率不断上升。此外，影像技术和雷射治疗等诊断和治疗方法的重大技术进步也进一步推动了市场的成长。

市场动态：

预计在预测期内，协议等无机策略的日益普及也将推动市场成长。例如，2020年11月，製药公司工业 Co., Ltd.与临床阶段生物製药公司Lung Therapeutics, Inc.宣布在日本签署独家授权合约，Lung Tx将开发用于治疗局部胸膜积液的重组人单链尿激酶型胞浆素原原激活剂。

然而，在预测期内，认知度低、诊断延迟、诊断工具和治疗成本高以及缺乏专业知识和资源将阻碍全球胸膜疾病市场的成长。

本研究的主要特点

本报告对全球胸膜疾病市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025-2032 的市场规模和年复合成长率(CAGR)。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球胸膜疾病市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行的分析。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球胸膜疾病市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球胸膜疾病市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.20%	2032 Value Projection:	USD 9.37 Bn

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The Global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

By Disease Types:
- Pleurisy
- Pleural Effusion
- Pneumothelioma
- Mesothelioma
- Others
By Diagnostic Tools:
- Imaging Techniques
- Molecular Diagnostics
- Thoracoscopy and Pleuroscopy
By Treatment Modalities:
- Medications
- Thoracentesis and Pleurodesis
- Minimally Invasive Interventions
- Surgical Interventions
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Research and Academic Institutions
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profile:
- Bristol Myers Squibb
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Boehringer Ingelheim International GmbH
- Sanofi
- AbbVie Inc.
- Braun SE
- Becton, Dickinson and Company
- Bicakcilar
- Biometrix
- Cook Medical
- Grena
- Redax
- Rocket Medical
- Smith Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Pleural Diseases, By Disease Type
- Market Pleural Diseases, By Diagnostic Tools
- Market Pleural Diseases, By Treatment Modalities
- Market Pleural Diseases, By End User
- Market Pleural Diseases, By Geography/Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Respiratory diseases
- Restraints
Limited Availability of Expertise and Resources
- Opportunities
Emerging Biomarkers and Precision Medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pleurisy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pleural Effusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pneumothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Mesothelioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Imaging Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 20218-2032, (US$ Billion)
Thoracoscopy and Pleuroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Thoracentesis and Pleurodesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Minimally Invasive Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bicakcilar
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biometrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Grena
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Redax
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rocket Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Smith Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

胸膜疾病市场按疾病类型、诊断工具、治疗方法、最终用户和地区划分

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市场动态：

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

第四章。全球胸膜疾病市场-冠状病毒（COVID-19）大流行的影响

5. 2020-2032 年全球胸膜疾病市场（依疾病类型）

6. 2020-2032 年全球胸膜疾病市场（依诊断工具划分）

7. 全球胸膜疾病市场（依治疗方法），2020-2032 年

8. 2020 年至 2032 年全球胸膜疾病市场（依最终使用者划分）

9. 2020-2032 年全球胸膜疾病市场（按地区）

第十章竞争格局

第 11 章章节

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

胸膜疾病市场按疾病类型、诊断工具、治疗方法、最终用户和地区划分

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

市场动态：

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

第四章。全球胸膜疾病市场-冠状病毒（COVID-19）大流行的影响

5. 2020-2032 年全球胸膜疾病市场（依疾病类型）

6. 2020-2032 年全球胸膜疾病市场（依诊断工具划分）

7. 全球胸膜疾病市场（依治疗方法），2020-2032 年

8. 2020 年至 2032 年全球胸膜疾病市场（依最终使用者划分）

9. 2020-2032 年全球胸膜疾病市场（按地区）

第十章 竞争格局

第 11 章 章节

Market Dynamics:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Pleural Diseases Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2020-2032, (US$ Bn)

7. Global Pleural Diseases Market, By Treatment Modalities, 2020-2032, (US$ Bn)

8. Global Pleural Diseases Market, By End User, 2020-2032, (US$ Bn)

9. Global Pleural Diseases Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

第一章调查目的与前提条件

第二章市场展望

第十章竞争格局

第 11 章章节